OPINION PIECE | COVID-19 reminds us why we invest in Australian health and medical research

Not since World War II, has Australia and the world been under such strict constraints, with limits on where we can travel, what we can buy and who we can socialise with.

Our scientists, like our health workforce, are working around the clock, racing to find the best possible solutions to this global health crisis. As our Prime Minister has said, this crisis could last for six months and indeed beyond. It is in these trying times that Australians look to health and medical researchers for answers.

Health and medical research must also be part of the political solution, with our researchers standing next to our leaders, both advising and supporting, as they make the crucial decisions that affect everyone.

Our world-leading researchers have been helping explain what this virus is, how it behaves and spreads, how to detect it and how we can protect ourselves. For more than 80 years, we Australians have been investing in our research workforce; via the National Health and Medical Research Council (NHMRC), the CSIRO, and more recently, the Medical Research Future Fund (MRFF) and, it is in times like these, that we reap the returns on these investments.

The sane, definitive way out of this crisis is an effective treatment for those infected and the development of a vaccine scaled up and produced en masse to protect the wider population.

Australia is leading the charge in many aspects; we have research leaders such as Professor Raina MacIntyre, Professor of Global Biosecurity, at UNSW’s Kirby Institute tracking Australia’s circumstances against the spread of COVID-19 in other nations so we can plan the next phase.  James McCaw, Professor of Mathematical Biology at the University of Melbourne is using mathematical modelling to develop scenarios that assist that decision-making.

Researchers such as Professor Sharon Lewin, Director of the Doherty Institute has her team isolating, growing and monitoring how the immune system responds to the virus. This research capability is no accident as for several years the Doherty Institute has been leading research, funded by Australia’s NHMRC, to prepare Australia for such a situation.

The University of Queensland’s Professor Paul Young is leading the team that is developing candidate vaccines and aims to commence a trial by July. They believe that by bringing vaccine manufacture forward, to run in parallel with clinical trials, they could have a vaccine ready by as early as January. Reducing the vaccine development time to 12 months would be a remarkable achievement.

Again, this is no accident; the work at UQ on new vaccine programs started in 2018 with funding from the Coalition for Epidemic Preparedness Innovations and has been focused on COVID 19 since January this year. And all of this is drawing on the work of CSIRO and its expertise in handling viruses, and in vaccine manufacture.

As many of us experience anxiety and the inconvenience of the seemingly bizarre panic buying, leading behavioural researchers, such as Dr Paul Harrison, Chair of Consumer Behaviour at Deakin University, have explained this is an emotional and understandable response to fear, an attempt to regain control in an uncertain situation.

Researchers and experts have been able to give us information we need to empower us to re-assert some control; exercising basic hand hygiene, working remotely and physical distancing or isolation if exposed to the virus.

And while it is our leaders who need to make the big decisions, they are emphasising that they are acting on expert advice. And this is critical to our confidence in them, because this is what we as a community expect that the response to a pandemic is based in science, it is rational and implementable.

Together our community – political, business and community leaders; health care providers; individuals and families – will come through this current crisis, and the contributions being made by our researchers, medics and nurses are helping ensure the best possible outcome for us all.

We are in a very different place to where we were a century ago, when the Spanish Flu struck, as we can deploy our world-class capabilities to rapidly respond using evidence-based research.   This pandemic shines a massive spotlight on the crucial importance of investment in health and medical research in Australia. It is vital for our health and our national security. We are proud of our research and medical workforce and we are exceptionally grateful that they are here.

By Chris Chapman Chair and Nadia Levin, CEO and Managing Director, Research Australia on behalf of the Research Australia Board

Research Australia is the national peak body for Australian health and medical research, representing all stages of the research pipeline, from universities and medical research institutes through to health corporates, hospitals and consumers.

www.researchaustralia.org 

 

The Role of Digital Technology in a Changing Health System

On Thursday 30 January 2020, Telstra Health and Research Australia co-hosted an event highlighting the vital role of digital technology in Australia’s changing health system. Research Australia members and Telstra Health partners from across the entire health and medical research pipeline convened to network and share their thoughts on this important subject over a drink to see in the new year.

Telstra Health’s Managing Director and Research Australia Board Director, Professor Mary Foley AM and Nadia Levin, Research Australia’s CEO and Managing Director, both spoke at the event sharing their views on the developing role of information technology in all aspects of health and health and medical research.

Professor Foley provided her insights on Telstra Health’s role supporting governments, health system managers, and healthcare providers to deliver high quality, equitable, and accessible care in an increasingly complex and specialised health system.

Nadia Levin highlighted the growing need for Australia’s health sector to utilise the many revolutionary benefits current and future digital information technologies can provide. Nadia gave examples from Research Australia’s members making ground-breaking progress in digital technology and later took a moment away from space medicine to focus on the patient, who is at the core of all health and medical research. Focusing on current health outcomes, Nadia acknowledged how something as simple as a digital sensor in an incontinence pad can positively impact a patient in aged care.

 

From left to right: Alex White, Telstra Health; Prof Mary Foley AM, Managing Director, Telstra Health; and Nadia Levin, CEO and Managing Director, Research

 

The evening included a Q&A session with an interactive audience wanting further discussion on the importance of addressing Australia’s health data privacy concerns.   The Frontiers Health and Medical Research funding initiative was also a hot topic of discussion with attendees highlighting the need for greater acknowledgement of the innovative and research-based nature of digital information technology.

 

From left to right: Professor Chris Cowell, Director of Research, Sydney Children’s Hospital Network; and Peter Wills AC, Deputy Chair of the Research Australia Board

 

 

From left to right: A/Prof Annette Schmiede, Director, Research Australia; and Dr Lana McClements, University of Technology Sydney

 

 

From left to right: Dr Henry Cutler Macquarie University Centre for Health Economy & Peter Wills AC Deputy Chair Research Australia

Australian Scientists to Develop a Vaccine for the Wuhan Coronavirus

Research Australia welcomes the news that one of our members, the University of Queensland, has been asked to develop a vaccine for the recent Wuhan Coronavirus outbreak. Through the use of new technologies, the University plans to develop the vaccine within an unprecedented timeframe of 6 months. If successfully discovered, the vaccine may be used as a primary strategy to contain the coronavirus outbreak.

Click here to see the University of Queensland’s news article.

Doherty Institute first to share successfully grown Wuhan Coronavirus

Scientists from the University of Melbourne and The Royal Melbourne Hospital’s Doherty Institute are the first to share successfully grown Wuhan Coronavirus in a laboratory setting. As a member of Research Australia, we commend the University of Melbourne and the Doherty Institute for their important breakthrough that will play a key role in speeding up diagnosis and aid in the development of a vaccine.

Click here to view the Doherty Institute’s media release.